These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 21116606)

  • 1. New aspects of an old drug: metformin as a glucagon-like peptide 1 (GLP-1) enhancer and sensitiser.
    Cho YM; Kieffer TJ
    Diabetologia; 2011 Feb; 54(2):219-22. PubMed ID: 21116606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin regulates the incretin receptor axis via a pathway dependent on peroxisome proliferator-activated receptor-α in mice.
    Maida A; Lamont BJ; Cao X; Drucker DJ
    Diabetologia; 2011 Feb; 54(2):339-49. PubMed ID: 20972533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Add-on therapy with anagliptin in Japanese patients with type-2 diabetes mellitus treated with metformin and miglitol can maintain higher concentrations of biologically active GLP-1/total GIP and a lower concentration of leptin.
    Osonoi T; Saito M; Hariya N; Goto M; Mochizuki K
    Peptides; 2016 Dec; 86():118-125. PubMed ID: 27780736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GIP and GLP-1 as incretin hormones: lessons from single and double incretin receptor knockout mice.
    Hansotia T; Drucker DJ
    Regul Pept; 2005 Jun; 128(2):125-34. PubMed ID: 15780432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral administration of corn zein hydrolysate stimulates GLP-1 and GIP secretion and improves glucose tolerance in male normal rats and Goto-Kakizaki rats.
    Higuchi N; Hira T; Yamada N; Hara H
    Endocrinology; 2013 Sep; 154(9):3089-98. PubMed ID: 23798598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of dipeptidyl peptidase-IV activity by metformin enhances the antidiabetic effects of glucagon-like peptide-1.
    Green BD; Irwin N; Duffy NA; Gault VA; O'harte FP; Flatt PR
    Eur J Pharmacol; 2006 Oct; 547(1-3):192-9. PubMed ID: 16945366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel GIP analogue, ZP4165, enhances glucagon-like peptide-1-induced body weight loss and improves glycaemic control in rodents.
    Nørregaard PK; Deryabina MA; Tofteng Shelton P; Fog JU; Daugaard JR; Eriksson PO; Larsen LF; Jessen L
    Diabetes Obes Metab; 2018 Jan; 20(1):60-68. PubMed ID: 28598027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addition of metformin to exogenous glucagon-like peptide-1 results in increased serum glucagon-like peptide-1 concentrations and greater glucose lowering in type 2 diabetes mellitus.
    Cuthbertson J; Patterson S; O'Harte FP; Bell PM
    Metabolism; 2011 Jan; 60(1):52-6. PubMed ID: 20152998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of aerobic exercise with or without metformin on plasma incretins in type 2 diabetes.
    Eshghi SR; Bell GJ; Boulé NG
    Can J Diabetes; 2013 Dec; 37(6):375-80. PubMed ID: 24321717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non-glucose induced insulin secretion in patients with type 2 diabetes mellitus.
    Aaboe K; Knop FK; Vilsbøll T; Deacon CF; Holst JJ; Madsbad S; Krarup T
    Diabetes Obes Metab; 2010 Apr; 12(4):323-33. PubMed ID: 20380653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential New Approaches to Modifying Intestinal GLP-1 Secretion in Patients with Type 2 Diabetes Mellitus : Focus on Bile Acid Sequestrants.
    Holst JJ; McGill MA
    Clin Drug Investig; 2012 Jan; 32(1):1-14. PubMed ID: 27933595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut peptides in the treatment of diabetes mellitus.
    Vahl TP; D'Alessio DA
    Expert Opin Investig Drugs; 2004 Mar; 13(3):177-88. PubMed ID: 15013938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of increase in plasma intact GLP-1 by metformin in type 2 diabetes: stimulation of GLP-1 secretion or reduction in plasma DPP-4 activity?
    Wu T; Thazhath SS; Bound MJ; Jones KL; Horowitz M; Rayner CK
    Diabetes Res Clin Pract; 2014 Oct; 106(1):e3-6. PubMed ID: 25172519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function.
    Shu L; Matveyenko AV; Kerr-Conte J; Cho JH; McIntosh CH; Maedler K
    Hum Mol Genet; 2009 Jul; 18(13):2388-99. PubMed ID: 19386626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incretin receptor null mice reveal key role of GLP-1 but not GIP in pancreatic beta cell adaptation to pregnancy.
    Moffett RC; Vasu S; Thorens B; Drucker DJ; Flatt PR
    PLoS One; 2014; 9(6):e96863. PubMed ID: 24927416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of TS-021 with metformin improves hyperglycemia and synergistically increases pancreatic β-cell mass in a mouse model of type 2 diabetes.
    Tajima A; Hirata T; Taniguchi K; Kondo Y; Kato S; Saito-Hori M; Ishimoto T; Yamamoto K
    Life Sci; 2011 Oct; 89(17-18):662-70. PubMed ID: 21872612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The entero-insular axis: implications for human metabolism.
    Ranganath LR
    Clin Chem Lab Med; 2008; 46(1):43-56. PubMed ID: 18020966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GPR119 regulates murine glucose homeostasis through incretin receptor-dependent and independent mechanisms.
    Flock G; Holland D; Seino Y; Drucker DJ
    Endocrinology; 2011 Feb; 152(2):374-83. PubMed ID: 21068156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterisation and antidiabetic utility of a novel hybrid peptide, exendin-4/gastrin/xenin-8-Gln.
    Hasib A; Ng MT; Khan D; Gault VA; Flatt PR; Irwin N
    Eur J Pharmacol; 2018 Sep; 834():126-135. PubMed ID: 30025814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.
    Svendsen PF; Nilas L; Madsbad S; Holst JJ
    Metabolism; 2009 May; 58(5):586-93. PubMed ID: 19375579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.